Viewing Study NCT02537158


Ignite Creation Date: 2025-12-25 @ 12:18 AM
Ignite Modification Date: 2026-02-20 @ 6:42 PM
Study NCT ID: NCT02537158
Status: UNKNOWN
Last Update Posted: 2016-03-15
First Post: 2015-08-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection
Sponsor: Chinese Academy of Medical Sciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None sorafenib View
None transcatheter arterial chemoembolization View
None hepatocellular carcinoma View
None microvascular invasion View